503 related articles for article (PubMed ID: 25996499)
1. The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey.
Merli M; Lucidi C; Di Gregorio V; Falcone M; Giannelli V; Lattanzi B; Giusto M; Ceccarelli G; Farcomeni A; Riggio O; Venditti M
PLoS One; 2015; 10(5):e0127448. PubMed ID: 25996499
[TBL] [Abstract][Full Text] [Related]
2. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.
Fernández J; Prado V; Trebicka J; Amoros A; Gustot T; Wiest R; Deulofeu C; Garcia E; Acevedo J; Fuhrmann V; Durand F; Sánchez C; Papp M; Caraceni P; Vargas V; Bañares R; Piano S; Janicko M; Albillos A; Alessandria C; Soriano G; Welzel TM; Laleman W; Gerbes A; De Gottardi A; Merli M; Coenraad M; Saliba F; Pavesi M; Jalan R; Ginès P; Angeli P; Arroyo V;
J Hepatol; 2019 Mar; 70(3):398-411. PubMed ID: 30391380
[TBL] [Abstract][Full Text] [Related]
3. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia.
Alexopoulou A; Vasilieva L; Agiasotelli D; Siranidi K; Pouriki S; Tsiriga A; Toutouza M; Dourakis SP
World J Gastroenterol; 2016 Apr; 22(15):4049-56. PubMed ID: 27099449
[TBL] [Abstract][Full Text] [Related]
4. Healthcare-associated and nosocomial bacterial infections in cirrhosis: predictors and impact on outcome.
Sargenti K; Prytz H; Strand A; Nilsson E; Kalaitzakis E
Liver Int; 2015 Feb; 35(2):391-400. PubMed ID: 25039438
[TBL] [Abstract][Full Text] [Related]
5. Multi-resistant bacteria in spontaneous bacterial peritonitis: a new step in management?
de Mattos AA; Costabeber AM; Lionço LC; Tovo CV
World J Gastroenterol; 2014 Oct; 20(39):14079-86. PubMed ID: 25339797
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and outcomes of bloodstream infection in patients with cirrhosis.
Bartoletti M; Giannella M; Caraceni P; Domenicali M; Ambretti S; Tedeschi S; Verucchi G; Badia L; Lewis RE; Bernardi M; Viale P
J Hepatol; 2014 Jul; 61(1):51-8. PubMed ID: 24681345
[TBL] [Abstract][Full Text] [Related]
7. New antibiotic strategies in patients with cirrhosis and bacterial infection.
Fernández J; Acevedo J
Expert Rev Gastroenterol Hepatol; 2015; 9(12):1495-500. PubMed ID: 26465070
[TBL] [Abstract][Full Text] [Related]
8. The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study.
Salerno F; Borzio M; Pedicino C; Simonetti R; Rossini A; Boccia S; Cacciola I; Burroughs AK; Manini MA; La Mura V; Angeli P; Bernardi M; Dalla Gasperina D; Dionigi E; Dibenedetto C; Arghittu M;
Liver Int; 2017 Jan; 37(1):71-79. PubMed ID: 27364035
[TBL] [Abstract][Full Text] [Related]
9. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
10. Community-onset healthcare-related urinary tract infections: comparison with community and hospital-acquired urinary tract infections.
Aguilar-Duran S; Horcajada JP; Sorlí L; Montero M; Salvadó M; Grau S; Gómez J; Knobel H
J Infect; 2012 May; 64(5):478-83. PubMed ID: 22285591
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study.
Fernández J; Acevedo J; Castro M; Garcia O; de Lope CR; Roca D; Pavesi M; Sola E; Moreira L; Silva A; Seva-Pereira T; Corradi F; Mensa J; Ginès P; Arroyo V
Hepatology; 2012 May; 55(5):1551-61. PubMed ID: 22183941
[TBL] [Abstract][Full Text] [Related]
12. Multidrug-resistant bacterial infections in patients with liver cirrhosis in a tertiary referral hospital.
Béjar-Serrano S; Del Pozo P; Fernández-de la Varga M; Benlloch S
Gastroenterol Hepatol; 2019 Apr; 42(4):228-238. PubMed ID: 30342782
[TBL] [Abstract][Full Text] [Related]
13. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
[TBL] [Abstract][Full Text] [Related]
14. A multicenter prospective study of infections related morbidity and mortality in cirrhosis of liver.
Baijal R; Amarapurkar D; Praveen Kumar HR; Kulkarni S; Shah N; Doshi S; Gupta D; Jain M; Patel N; Kamani P; Issar SK; Dharod M; Shah A; Chandnani M; Gautam S
Indian J Gastroenterol; 2014 Jul; 33(4):336-42. PubMed ID: 24879611
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and risk factors for multi-drug resistant hospital-acquired urinary tract infection in patients with liver cirrhosis: single center experience in Serbia.
Milovanovic T; Dumic I; Veličkovic J; Lalosevic MS; Nikolic V; Palibrk I
BMC Infect Dis; 2019 Feb; 19(1):141. PubMed ID: 30755176
[TBL] [Abstract][Full Text] [Related]
16. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
[TBL] [Abstract][Full Text] [Related]
17. Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis.
Fiore M; Gentile I; Maraolo AE; Leone S; Simeon V; Chiodini P; Pace MC; Gustot T; Taccone FS
Eur J Gastroenterol Hepatol; 2018 Mar; 30(3):329-336. PubMed ID: 29303883
[TBL] [Abstract][Full Text] [Related]
18. Multidrug-resistant bacterial infections in cirrhotic patients: an epidemiological study.
Zhao R; Ma J; Li P; Fang H; Sun S; Wu W; Chen J; Zhao H; Jin L; Shi Y; Sheng J
Expert Rev Gastroenterol Hepatol; 2018 Nov; 12(11):1167-1174. PubMed ID: 30152255
[TBL] [Abstract][Full Text] [Related]
19. Bacterial pneumonia in patients with liver cirrhosis, with or without HIV co-infection: a possible definition of antibiotic prophylaxis associated pneumonia (APAP).
Cuomo G; Brancaccio G; Stornaiuolo G; Manno D; Gaeta GL; Mussini C; Puoti M; Gaeta GB
Infect Dis (Lond); 2018 Feb; 50(2):125-132. PubMed ID: 28851249
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.
Piano S; Singh V; Caraceni P; Maiwall R; Alessandria C; Fernandez J; Soares EC; Kim DJ; Kim SE; Marino M; Vorobioff J; Barea RCR; Merli M; Elkrief L; Vargas V; Krag A; Singh SP; Lesmana LA; Toledo C; Marciano S; Verhelst X; Wong F; Intagliata N; Rabinowich L; Colombato L; Kim SG; Gerbes A; Durand F; Roblero JP; Bhamidimarri KR; Boyer TD; Maevskaya M; Fassio E; Kim HS; Hwang JS; Gines P; Gadano A; Sarin SK; Angeli P;
Gastroenterology; 2019 Apr; 156(5):1368-1380.e10. PubMed ID: 30552895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
